SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma
Abstract Background Solute carrier family 38 member 5 (SLC38A5) is an amino acid transporter that plays a significant role in various cellular biological processes and may be involved in regulating the progression of tumors However, its function and underlying mechanism in osteosarcoma remain unexpl...
Saved in:
Main Authors: | Xinghan Huang, Kezhou Xia, Zhun Wei, Wenda Liu, Zicheng Wei, Weichun Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-11-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-024-05803-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer
by: Jingyang Li, et al.
Published: (2025-02-01) -
Dipeptide alanine-glutamine ameliorates retinal neurodegeneration in an STZ-induced rat model
by: Yuhan Zhang, et al.
Published: (2024-11-01) -
The homeobox family gene signature predicts the prognosis of osteosarcoma and correlates with immune invasion
by: Wenda Liu, et al.
Published: (2025-01-01) -
CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway
by: Zicheng Wei, et al.
Published: (2024-12-01) -
Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms
by: Sulaiman K. Marafie, et al.
Published: (2024-12-01)